SCHEMBL95736

SCHEMBL95736

[CH2]c1ccc(C(=O)N2CCCCCC2)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.80
ALDH1A1 P00352 3/20 0.80
KMT2A Q03164 2/20 0.61
MEN1 O00255 1/20 0.61
TSHR P16473 1/20 0.61
MAPK1 P28482 1/20 0.59
CA12 O43570 2/20 0.59
CA1 P00915 2/20 0.59
CA2 P00918 2/20 0.59
CA7 P43166 2/20 0.59
CA9 Q16790 2/20 0.59
CA14 Q9ULX7 2/20 0.59
MLYCD O95822 2/20 0.58
USP2 O75604 1/20 0.58
MAPT P10636 1/20 0.57
LMNA P02545 1/20 0.57
MBTD1 Q05BQ5 3/20 0.56
L3MBTL3 Q96JM7 3/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
MAOA P21397 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL95029 1.00 HPGD (0.80) HPGDALDH1A1KMT2AMEN1TSHR
SCHEMBL2538732 0.98 HPGD (0.76) HPGDALDH1A1KMT2AMEN1TSHR
SCHEMBL7132525 0.89 HPGD (1.00) HPGDALDH1A1KMT2AMEN1TSHR
SCHEMBL27479149 0.89 HPGD (1.00) HPGDALDH1A1KMT2AMEN1TSHR
SCHEMBL10721733 0.87 HPGD (0.95) HPGDALDH1A1KMT2AMEN1TSHR
SCHEMBL95490 0.84 L3MBTL3 (0.85) ALDH1A1KMT2AMEN1MBTD1L3MBTL3
SCHEMBL2539905 0.83 HPGD (0.71) HPGDALDH1A1KMT2AMEN1TSHR
SCHEMBL95807 0.83 L3MBTL3 (0.68) HPGDALDH1A1KMT2AMEN1MBTD1
SCHEMBL4050706 0.82 HPGD (0.83) HPGDALDH1A1KMT2AMEN1TSHR
SCHEMBL3905925 0.82 HPGD (0.83) HPGDALDH1A1KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB HPGD 2146/4885ALDH1A1 2948/4885KMT2A 1059/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 HPGD 2322/4885ALDH1A1 2458/4885KMT2A 2732/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 HPGD 2322/4885ALDH1A1 2458/4885KMT2A 2732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.